Identification of novel genes and pathways involved in resistance to HER2-targeting agents in breast cancer

被引：0
|
作者：
Wetterskog, Daniel [1 ]
Shiu, Kai-Keen [1 ]
Chong, Irene [1 ]
Meijer, Titia [1 ]
Natrajan, Rachael [1 ]
Lord, Christopher J. [1 ]
Ashworth, Alan [1 ]
Reis-Filho, Jorge S. [1 ]
机构：
[1] ICR, London, England
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-4987
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4987
引用
收藏
页数：1
相关论文
共 50 条
  • [1] EVOLUTION OF HER2-TARGETING IN METASTATIC BREAST CANCER
    Bartsch, Rupert
    Balic, Marija
    [J]. BREAST CARE, 2022, 17 (06) : 521 - 522
  • [2] Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis
    Lu, Xin
    Gao, Chundi
    Liu, Cun
    Zhuang, Jing
    Su, Peiying
    Li, Huayao
    Wang, Xue
    Sun, Changgang
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (08)
  • [3] Making Sense of Dual HER2-Targeting in Early Breast Cancer?
    Carey, Lisa A.
    Barry, William
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (09)
  • [4] Resistance mechanisms to HER2-targeting treatment in HER2-positive gastric cancer
    Kang, Kyo Hwa
    Nam, Ah-Rong
    Park, Ji Eun
    Bang, Ju-Hee
    Ling, Jin
    Jin, Mei Hua
    Kim, Tae Yong
    Han, Sae-Won
    Song, Sang-Hyun
    Im, Seock-Ah
    Kim, Tae-You
    Oh, Do-Youn
    Bang, Yung-Jue
    [J]. CANCER RESEARCH, 2015, 75
  • [5] Identification of key genes involved in HER2-positive breast cancer
    Zhong, B. -L.
    Bian, L. -J.
    Wang, G. -M.
    Zhou, Y. -F.
    Chen, Y. -Y.
    Peng, F.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (04) : 664 - 672
  • [6] Trastuzumab deruxtecan and other HER2-targeting agents for the treatment of HER2-positive gastric cancer
    Ishii, Takahiro
    Shitara, Kohei
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (11) : 1193 - 1201
  • [7] Perspectives of HER2-targeting in gastric and esophageal cancer
    Gerson, James N.
    Skariah, Sam
    Denlinger, Crystal S.
    Astsaturov, Igor
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (05) : 531 - 540
  • [8] HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment
    Weigelt, Britta
    Lo, Alvin T.
    Park, Catherine C.
    Gray, Joe W.
    Bissell, Mina J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2010, 122 (01) : 35 - 43
  • [9] HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment
    Britta Weigelt
    Alvin T. Lo
    Catherine C. Park
    Joe W. Gray
    Mina J. Bissell
    [J]. Breast Cancer Research and Treatment, 2010, 122 : 35 - 43
  • [10] Synergistic Antitumor Effect of S-1 and HER2-Targeting Agents in Gastric Cancer with HER2 Amplification
    Tanizaki, Junko
    Okamoto, Isamu
    Takezawa, Ken
    Tsukioka, Sayaka
    Uchida, Junji
    Kiniwa, Mamoru
    Fukuoka, Masahiro
    Nakagawa, Kazuhiko
    [J]. MOLECULAR CANCER THERAPEUTICS, 2010, 9 (05) : 1198 - 1207
12345